Home
NovoCure NVCR paid Tarplin, Downs & Young $80K for lobbying in Q3 2024 · Medicare, Health Issues
Trade details
- Type
- Lobbying report
- Amount
- $80,000
- Quarter
- Q3 2024
- Stock
- NovoCure NVCR
- Client
- Novocure
- Reported
- 24/10/18
Up 0.0% from last quarter
What else happened in NovoCure around then
Filed or reported within 30 days of the trade day · 24/08/31~24/10/30Novocure's other lobbying reports
- Novocure
LobbyingNovoCure
LobbyingNovoCure
NVCR
$60K
$60K
Reported 07/20
for Q2
- Novocure
LobbyingNovoCure
LobbyingNovoCure
NVCR
$20K
$20K
Reported 07/20
for Q2
- Novocure
LobbyingNovoCure
LobbyingNovoCure
NVCR
$80K
$80K
Reported 07/20
for Q2
- Novocure
LobbyingNovoCure
LobbyingNovoCure
NVCR
$160K
$160K
Reported 07/19
for Q2
- Novocure
LobbyingNovoCure
LobbyingNovoCure
NVCR
$40K
$40K
Reported 04/20
for Q1